Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pekka Lahdenne

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
Studies in Health Technology and Informatics|April 22, 2018
Improving Patient Experience in a Children's Hospital: New Digital Services for Children and Their FamiliesNina Karisalmi, Johanna Kaipio, Pekka Lahdenne
The Pediatric Infectious Disease Journal|July 13, 2004
Facial nerve palsy after human herpesvirus 6 infectionAnne Pitkäranta, Pekka Lahdenne, Heli Piiparinen
Clinical Rheumatology|October 1, 2010
Iron status during anti-TNF therapy in children with juvenile idiopathic arthritisKristiina Aalto, Visa Honkanen, Pekka Lahdenne
Pediatric Rheumatology Online Journal|February 2, 2017
Fecal calprotectin in juvenile idiopathic arthritis patients related to drug useKristiina Aalto, Pekka Lahdenne, Kaija-Leena Kolho
BMC Health Services Research|April 28, 2020
Measuring patient experiences in a Children's hospital with a medical clowning intervention: a case-control studyNina Karisalmi, Katja Mäenpää, Johanna Kaipio, et al.
Rheumatology (Oxford, England)|December 16, 2014
Occurrence of adverse events in patients with JIA receiving biologic agents: long-term follow-up in a real-life settingMaarit Tarkiainen, Pirjo Tynjälä, Paula Vähäsalo, et al.
The Journal of Rheumatology|November 5, 2002
Hepatotoxicity in patients with juvenile idiopathic arthritis receiving longterm methotrexate therapyPekka Lahdenne, Juhani Rapola, Heikki Ylijoki, et al.
Duodecim; Laaketieteellinen Aikakauskirja|March 29, 2016
[Special features of biological drug therapy in children]Kristiina Aalto, Sanna Leinonen, Kaija-Leena Kolho, et al.
Annals of the Rheumatic Diseases|October 28, 2006
Infliximab and etanercept in the treatment of chronic uveitis associated with refractory juvenile idiopathic arthritisPirjo Tynjälä, Päivi Lindahl, Visa Honkanen, et al.
Studies in Health Technology and Informatics|February 12, 2019
Development of the Patient Experience Questionnaire for Parents of Pediatric Patients (PEQP)Johanna Kaipio, Nina Karisalmi, Kari Hiekkanen, et al.
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Studies in Health Technology and Informatics|April 22, 2018
Improving Patient Experience in a Children's Hospital: New Digital Services for Children and Their FamiliesNina Karisalmi, Johanna Kaipio, Pekka Lahdenne
The Pediatric Infectious Disease Journal|July 13, 2004
Facial nerve palsy after human herpesvirus 6 infectionAnne Pitkäranta, Pekka Lahdenne, Heli Piiparinen
Clinical Rheumatology|October 1, 2010
Iron status during anti-TNF therapy in children with juvenile idiopathic arthritisKristiina Aalto, Visa Honkanen, Pekka Lahdenne
Pediatric Rheumatology Online Journal|February 2, 2017
Fecal calprotectin in juvenile idiopathic arthritis patients related to drug useKristiina Aalto, Pekka Lahdenne, Kaija-Leena Kolho
BMC Health Services Research|April 28, 2020
Measuring patient experiences in a Children's hospital with a medical clowning intervention: a case-control studyNina Karisalmi, Katja Mäenpää, Johanna Kaipio, et al.
Rheumatology (Oxford, England)|December 16, 2014
Occurrence of adverse events in patients with JIA receiving biologic agents: long-term follow-up in a real-life settingMaarit Tarkiainen, Pirjo Tynjälä, Paula Vähäsalo, et al.
The Journal of Rheumatology|November 5, 2002
Hepatotoxicity in patients with juvenile idiopathic arthritis receiving longterm methotrexate therapyPekka Lahdenne, Juhani Rapola, Heikki Ylijoki, et al.
Duodecim; Laaketieteellinen Aikakauskirja|March 29, 2016
[Special features of biological drug therapy in children]Kristiina Aalto, Sanna Leinonen, Kaija-Leena Kolho, et al.
Annals of the Rheumatic Diseases|October 28, 2006
Infliximab and etanercept in the treatment of chronic uveitis associated with refractory juvenile idiopathic arthritisPirjo Tynjälä, Päivi Lindahl, Visa Honkanen, et al.
Studies in Health Technology and Informatics|February 12, 2019
Development of the Patient Experience Questionnaire for Parents of Pediatric Patients (PEQP)Johanna Kaipio, Nina Karisalmi, Kari Hiekkanen, et al.
Pageof 7